Anders Elm Pedersen

Anders Elm Pedersen is an experienced professional in the fields of immunology and clinical development, currently serving as the Editor in Chief for Immunopharmacology and Immunotoxicology and as an Associate Editor at Frontiers in Immunology focusing on Cancer Immunity and Immunotherapy. As a professor at Roskilde University and a physician at Region Sjælland, Anders has contributed significantly to academia and clinical practice. Previously held positions include Senior Medical Director at Nerviano Medical Sciences, Director of Early Development and Translational Medicine at Almirall, and Medical Director at Merck Group, where responsibilities included managing medical affairs across multiple therapeutic areas. Anders holds a Doctor of Medical Science (DMSc), a Doctor of Philosophy (PhD), and a Doctor of Medicine (M.D.) from the University of Copenhagen, reflecting a strong academic background complemented by clinical expertise.